Eric Patzer - Net Worth and Insider Trading
Eric Patzer Net Worth
The estimated net worth of Eric Patzer is at least $38,617 dollars as of 2024-06-05. Eric Patzer is the Director of Aridis Pharmaceuticals Inc and owns about 702,132 shares of Aridis Pharmaceuticals Inc (ARDS) stock worth over $38,617. Details can be seen in Eric Patzer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric Patzer has not made any transactions after 2021-07-27 and currently still holds the listed stock(s).
Transaction Summary of Eric Patzer
Eric Patzer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Patzer owns 1 companies in total, including Aridis Pharmaceuticals Inc (ARDS) .
Click here to see the complete history of Eric Patzer’s form 4 insider trades.
Insider Ownership Summary of Eric Patzer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc | 2021-07-27 | director & 10 percent owner |
Eric Patzer Latest Holdings Summary
Eric Patzer currently owns a total of 1 stock. Eric Patzer owns 702,132 shares of Aridis Pharmaceuticals Inc (ARDS) as of July 27, 2021, with a value of $38,617.
Latest Holdings of Eric Patzer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc | 2021-07-27 | 702,132 | 0.06 | 38,617 |
Holding Weightings of Eric Patzer
Eric Patzer Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Patzer has made a total of 1 transactions in Aridis Pharmaceuticals Inc (ARDS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aridis Pharmaceuticals Inc is the acquisition of 5,175 shares on July 27, 2021, which cost Eric Patzer around $25,047.
Insider Trading History of Eric Patzer
- 1
Eric Patzer Trading Performance
GuruFocus tracks the stock performance after each of Eric Patzer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Patzer is -29.59%. GuruFocus also compares Eric Patzer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Patzer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Patzer's insider trading performs compared to the benchmark.
Performance of Eric Patzer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -23.06 | | | | | |
| Relative Return to S&P 500(%) | -25.51 | | | | | |
Eric Patzer Ownership Network
Eric Patzer Owned Company Details
What does Aridis Pharmaceuticals Inc do?
Who are the key executives at Aridis Pharmaceuticals Inc?
Eric Patzer is the director & 10 percent owner of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include 10 percent owner Fibrosis Foundation Cystic , Chief Medical Officer Hasan Jafri , and director & 10 percent owner & CEO & CSO & Director Vu Truong .
Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aridis Pharmaceuticals Inc Insider Transactions
Eric Patzer Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Patzer. You might contact Eric Patzer via mailing address: 5941 Optical Ct., San Jose Ca 95138.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
